Early initiation of ofatumumab delays disability progression in people with relapsing multiple sclerosis: 6-year results from ALITHIOS open-label extension study

Category Primary study
ConferenceThe 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Year 2024
This article has no abstract
Epistemonikos ID: 1e7a954b644f01c80a8537540018cddc3026fd55
First added on: Apr 04, 2026